Will Inovio Pharmaceuticals Make a Fortune Off Its Coronavirus Vaccine?
Inovio Pharmaceuticals (NASDAQ: INO) is easily one of the most volatile stocks on the market, thanks in no small part to the company's COVID-19 vaccine, INO-4800. With the company promising to produce about 1 million vaccines by the end of the year for testing and emergency use purposes, there's plenty of excitement surrounding this stock right now.
However, some industry experts think Inovio's COVID-19 vaccine won't be the blockbuster that many investors are making it out to be. Let's find out exactly how much money Inovio can make from this vaccine, and whether that by itself would make this stock a buy.
Image source: Getty Images.
Source Fool.com
